Brigatinib Tablets

Drugs for the treatment of lung cancer
Brigatinib tablets are innovative drugs in the field of lung cancer. They are used to treat ALK-positive locally advanced or metastatic non-small cell lung cancer. They were approved for marketing in China in March 2022. [1]
Brigatinib is a new ALK tyrosine kinase inhibitor. Its efficacy has been clinically proven in prolonging patient survival, controlling brain metastases, and improving quality of life. [1]